150943-34-3

Upstream product

• 220827-73-6 5-O-tert-butyldiphenylsilyl-1,2-O-isopropylidene-α-L-xylofuranose 
• 1005-56-7 phenylcarbonochloridothioate 
• 103763-14-0 (3aR,5S,6S,6aR)-5-{[(tert-butyldiphenylsilyl)oxy]methyl}-2,2-dimethyltetrahydro-2H-furo[2,3-d][1,3]dioxol-6-ol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 103763-12-8 5-O-tert-butyldiphenylsilyl-α,β-L-arabinofuranose 
• 41546-31-0 L-xylose 
• 114861-22-2 1,2-O-isopropylidene-α-L-xylofuranose 

Downstream Products

• 114925-52-9 <4R-(4α,5α)>-4-<(phenylmethoxy)methyl>-6-ethenyl-2,2-dimethyl-1,3-dioxane 
• 106799-17-1 (2R,4S)-1-<(phenylmethoxy)methyl>5-hexene-2,4-diol 
• 114925-53-0 3,5-dideoxy-2,4-O-(1-methylethylidene)-1-O-(phenylmethyl)-D-erythro-hexitol 
• 106799-18-2 3,5-dideoxy-6-O-<(1,1-dimethylethyl)dimethylsilyl>-2,4-O-(1-methylethylidene)-1-O-(phenylmethyl)-D-erythro-hexitol 
• 150943-37-6 (R)-1-((tert-butyldiphenylsilyl)oxy)-4-chloro-2-(methoxymethoxy)butane 
• 150943-35-4 (R)-1-O-(tert-butyldiphenylsilyl)-1,2,4-butanetriol 
• 150943-36-5 (R)-1-O-(tert-butyldiphenylsilyl)-4-chloro-1,2-butanediol 
• 150950-21-3 5-O-(tert-butyldiphenylsilyl)-3-deoxy-1,2-O-isopropylidene-β-L-treopentofuranose 
• 114861-37-9 3-deoxy-5-O-(phenylmethyl)-α-L-xylofuranose 
• 114861-24-4 3-deoxy-1,2-O-(1-methylethylidene)-5-O-(phenylmethyl)-α-L-xylofuranose 
• 106799-16-0 tert-Butyl-((3aS,5R,6aS)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-ylmethoxy)-diphenyl-silane 

Relevant academic research and scientific papers

An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acid

The racemic isosteric phosphonate of ganciclovir monophosphate (BW2482U89, SR3745, [3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acid, 1) has potent and selective in vitro activity against human cytomegalovirus. An enant

Total Synthesis of Amphoteronolide B and Amphotericin B. 1. Strategy and Stereocontrolled Construction of Key Building Blocks

The retrosynthetic analysis and strategy for the total synthesis of amphotericin B (1) and amphoteronolide B (2) is discussed.Focusing on subtle and repeated structural units, a retrosynthetic scheme was constructed that led to the recognition of readily